The largest database of trusted experimental protocols

P24 elisa kit

Manufactured by PerkinElmer

The P24 ELISA kit is a laboratory instrument used for the detection and quantification of the p24 antigen, a key component of the human immunodeficiency virus (HIV). This kit provides a reliable and standardized method for the analysis of p24 levels in various sample types.

Automatically generated - may contain errors

8 protocols using p24 elisa kit

1

Antiviral Screening of Test Compounds Against HIV-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
HIV-1 NL4–3 (multiplicity of infection = 0.001) was used to infect MT4 cells in the presence of various concentrations of the test compounds, and the CellTiter-Glo reagent was added in parallel for cytotoxicity studies.5 Virus replication was analyzed on day-4 postinfection using a p24 ELISA kit from PerkinElmer, and cytotoxicity was determined using a cell viability kit provided by Promega. The compound concentration that inhibited HIV-1 replication by 50% (EC50) and decreased the cell viability by 50% (IC50) was calculated by using the biostatistic software Calcusun (Biosoft). Gnidimacrin was used as a positive control.
+ Open protocol
+ Expand
2

Antiviral Potency and Cytotoxicity of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
HIV-1 NL4–3 (multiplicity of infection = 0.001) was used to infect MT4 cells in the presence of different concentrations of the test compounds, and cytotoxicity of these compounds to MT4 cells was evaluated by using a cell viability kit provided by Promega.8 (link) Fresh medium containing appropriate concentrations of the compounds was added to the culture 48 h after infection to maintain normal cell growth. Virus replication was analyzed on day-4 postinfection using a p24 ELISA kit from PerkinElmer. The CellTiter-Glo Luminescent Cell Viability Assay is a simple method of determining the viability of the cells in culture based on quantitation of ATP in metabolically active cells. The CellTiter-Glo reagent was added to the MT4 cells that were cultured parallel to the antiviral assays. The biostatistic software Calcusun (Biosoft) was used to calculate the compound concentration that inhibited HIV-1 replication by 50% (EC50) and decreased the cell viability by 50% (IC50). Gnidimacrin was used as a positive control.
+ Open protocol
+ Expand
3

Generation of Infectious HIV-1 Molecular Clones

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full-length genomes for T/F viruses were inferred as described in previous studies14 (link)25 (link). Infectious molecular clones (IMCs) were chemically synthesized and constructed for different T/F viruses from three subjects (CH0200, CH0228 and CH0078) as previously described2 (link)14 (link). Among them, CH0200a, CH0228a and CH0228b were reported in a previous study16 (link). The viral stocks were generated by transfecting the IMCs into 293T cells as described previously25 (link). The p24 concentrations of viral stocks were determined with the p24 ELISA kit (PerkinElmer, Waltham, MA) and TCID50 of viral stocks was determined on TZM-bl cells.
+ Open protocol
+ Expand
4

Antiviral Assay of Compounds Against HIV-1 in MT4 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HIV-1 NL4–3 (multiplicity of infection = 0.001) were used to infect MT4 cells in the presence of compounds at various concentrations in 96-well plates. Fresh medium containing appropriate concentrations of the compounds were added to the culture 48 h after infection to maintain normal cell growth. Virus replication was analyzed 4-day postinfection using p24 ELISA kit purchased from Perkin-Elmer.2h The viability of the cells in culture is based on quantitation of ATP in metabolically active cells using the CellTiter-Glo Luminescent Cell Viability Assay kit purchased from Promega. The CellTiter-Glo reagent was added to the MT4 cells that were cultured parallel to the antiviral assays. Cytotoxicity of the compounds to MT4 lymphocytes was performed using the CellTiter-Glo Luminescent Cell Viability Assay kit. A dose-response curve was established from three independent experiments. The anti-HIV-1 activity of each compound was assessed with 4-fold serial dilutions encompassing the inhibitory phase of the dose-response curve. The EC50 was then derived using the Quest Graph IC50 Calculator (https://www.aatbio.com/tools/ic50-calculator). Gnidimacrin was isolated from Stellera chamaejasme (Thymelaeaceae) in our previous study and used as a positive control in the assays.2c
+ Open protocol
+ Expand
5

HIV-1 p24 Antigen Quantification in CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated from whole blood via Ficoll-Paque. For each individual, CD4 + T cells isolated from the PBMCs by magnetic isolation (CD4 + T Cell Isolation Kit, Miltenyi Biotech) were cultured as previously described (Blankson et al., 2007 (link)). On day 13, culture supernatants were tested for the presence of HIV-1 p24 antigen with the Perkin Elmer p24 ELISA kit.
+ Open protocol
+ Expand
6

Viral Stock Amplification and CD4+ T Cell Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
One millilitre of supernatant recovered from the co-culture described above (Proviral and Replication-competent Virus Isolation) with the highest p24 concentration was amplified to generate a stock of patient virus. Pre-stimulated CD4 + T cells from HIV-negative individuals were isolated from PBMCs and spinoculated at 1200 × g and 37°C for 2 h with the three viral stocks obtained as described above with 250 ng p24 per 1 × 106 cells. The cells were washed prior to culturing 1 × 106 cells per mL of STCM in triplicate in a 48-well plate for seven days at 37 °C. Supernatant samples taken immediately after plating and on days 3, 5, and 7 were then tested for p24 concentration with the Perkin-Elmer p24 ELISA kit.
+ Open protocol
+ Expand
7

CD4+ T Cell Infection Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMC) were obtained through leukophereses from healthy donors as previously described [25] (link). The written consent was obtained from the donors and the study was approved by the Duke University Institutional Review Board. PBMCs were isolated using the Ficoll-Hypaque density gradients and lymphocytes were isolated by elutriation using standard techniques. CD4+ T cells were negatively selected from PBMCs or lymphocytes on an autoMACS Pro Separator using the CD4+ T cell Isolation Kit II (Miltenyi Biotec, Auburn, CA). Purified CD4+ T cells were stimulated for 3 days in RPMI1640 containing 10% fetal bovine serum (FBS), interleukin 2 (IL-2) (32 IU/ml; Advanced Biotechnologies, Columbia, MD), soluble anti-CD3 (0.2 µg/ml; eBioscience, San Diego, CA) and anti-CD28 (0.2 µg/ml; BD Bioscience, San Diego, CA). The stimulated CD4+ T cells (1×106) were infected with 1000 TCID50 of each virus (m.o.i≈0.001). After an incubation at 37°C for 4 hours, the cells were washed 3 times with RPMI 1640, and cultured in a 24-well plate in 600 µl of RPMI 1640 containing 10% FBS and IL-2 (32 IU/ml). Each virus was cultured in triplicates. Viral replication was monitored daily for 5 days by measuring the p24 concentration in the culture supernatant with the p24 ELISA kit (PerkinElmer, Waltham, MA).
+ Open protocol
+ Expand
8

Quantification of Latent HIV Reservoir

Check if the same lab product or an alternative is used in the 5 most similar protocols
A portion of GM or SAHA treated PBMCs from the above described RT-PCR experiment was used to determine the frequency of latently infected cells using a limiting dilution viral outgrowth assay method similar to that described by Siliciano el al.23 (link) The medium with compounds was completely removed by washing the PBMCs with culture medium. The cells were then activated with 0.5 μg/mL of PHA for 48 hours. A series of five-fold dilutions of the activated patient PBMCs, starting at 5 × 106, were co-cultured with PHA-activated uninfected donors’ PBMCs at a ratio of 1 to 2 (patient to normal PBMCs). The cell mixtures were cultured for 10 days and the culture medium was refreshed every 2 days. The culture supernatants were tested for HIV-1 p24 protein on day 10 using a Perkin Elmer P24 ELISA kit. The frequency of latently infected cells among the input patient’s PBMCs was calculated by a maximum likelihood method as previously described and is expressed as infectious units per million.23 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!